Risk factors for late-onset generalized anxiety disorder: Results from a 12-year prospective cohort (The ESPRIT study)

Translational Psychiatry

Volumn 5, Issue 3, 2015, Pages

  Zhang, X ^a,b,c   Norton, J ^a,b   Carriere I ^a,b   Ritchie, K ^a,b,d   Chaudieu, I ^a,b   Ancelin, M L ^a,b  

^a Montpellier 1 University   (France)

^b INSERM U1061   (France)

^c SHANDONG MENTAL HEALTH CENTER   (China)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEPRESSION; DSM-IV; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GENERALIZED ANXIETY DISORDER; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; LATE ONSET DISORDER; LIFE EVENT; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; PARENTAL DEPRIVATION; PHOBIA; POVERTY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; RISK FACTOR; ANXIETY DISORDERS; FRANCE; GERIATRIC ASSESSMENT; PREVALENCE; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA;

AGED; ANXIETY DISORDERS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; FRANCE; GERIATRIC ASSESSMENT; HUMANS; LIFE STYLE; MALE; PREVALENCE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 84989354990     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2015.31     Document Type: Article

References (48)

1. Kessler RC, Keller MB, Wittchen HU. The epidemiology of generalized anxiety disorder. Psychiatr Clin North Am 2001; 24: 19-39.
2. Hoge EA, Ivkovic A, Fricchione GL. Generalized anxiety disorder: diagnosis and treatment. Br Med J 2012; 345: 37-42.
3. Parmentier H, Garcia-Campayo J, Prieto R. Comprehensive review of generalized anxiety disorder in primary care in Europe. Curr Med Res Opin 2013; 29: 355-367.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). American Psychiatric Press: Washington, DC, USA, 1994.
5. Moreno-Peral P, Conejo-Ceron S, Motrico E, Rodríguez-Morejón A, Fernández A, García-Campayo J et al. Risk factors for the onset of panic and generalised anxiety disorders in the general adult population: a systematic review of cohort studies. J Affect Disord 2014; 168C: 337-348.
6. Schoevers RA, Deeg DJ, van Tilburg W, Beekman AT. Depression and generalized anxiety disorder: co-occurrence and longitudinal patterns in elderly patients. Am J Geriatr Psychiatry 2005; 13: 31-39.
7. Chou KL, Mackenzie CS, Liang K, Sareen J. Three-year incidence and predictors of first-onset of DSM-IV mood, anxiety, and substance use disorders in older adults: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2011; 72: 144-155.
8. Ritchie K, Artero S, Beluche I, Ancelin ML, Mann A, Dupuy AM et al. Prevalence of DSM-IV psychiatric disorder in the French elderly population. Br J Psychiatry 2004; 184: 147-152.
9. Ancelin ML, Ripoche E, Dupuy AM, Barberger-Gateau P, Auriacombe S, Rouaud O et al. Sex differences in the associations between lipid levels and incident dementia. J Alzheimers Dis 2013; 34: 519-528.
10. Ritchie K, Norton J, Mann A, Carriere I, Ancelin ML. Late-onset agoraphobia: general population incidence and evidence for a clinical subtype. Am J Psychiatry 2013; 170: 790-798.
11. Lecrubier Y, Sheehan D, Weiller E, Amorim P, Bonora I, Sheehan K et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 1997; 12: 224-231.
12. Harwood RH, Prince MJ, Mann AH, Ebrahim S. The prevalence of diagnoses, impairments, disabilities and handicaps in a population of elderly people living in a defined geographical area: the Gospel Oak project. Age Ageing 1998; 27: 707-714.
13. Norton J, Ancelin ML, Stewart R, Berr C, Ritchie K, Carrière I. Anxiety symptoms and disorder predict activity limitations in the elderly. J Affect Disord 2012; 141: 276-285.
14. Ancelin ML, Carrière I, Boulenger JP, Malafosse A, Stewart R, Cristol JP et al. Gender and genotype modulation of the association between lipid levels and depressive symptomatology in community-dwelling elderly (the ESPRIT study). Biol Psychiatry 2010; 68: 125-132.
15. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
16. Isaacs B, Kennie AT. The Set test as an aid to the detection of dementia in old people. Br J Psychiatry 1973; 123: 467-470.
17. Benton A. Manuel pour l'Application du Test de Rétention Visuelle: Applications Cliniques et Expérimentales. Centre de Psychologie Appliquée: Paris, France, 1965.
18. Reitan RM Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958; 8: 271-276.
19. Ritchie K, Jaussent I, Stewart R, Dupuy AM, Courtet P, Ancelin ML et al. Association of adverse childhood environment and 5-HTTLPR Genotype with late-life depression. J Clin Psychiatry 2009; 70: 1281-1288.
20. Hoehn-Saric R, McLeod DR, Funderburk F, Kowalski P. Somatic symptoms and physiologic responses in generalized anxiety disorder and panic disorder: an ambulatory monitor study. Arch Gen Psychiatry 2004; 61: 913-921.
21. Chaudieu I, Beluche I, Norton J, Boulenger JP, Ritchie K, Ancelin ML. Abnormal reactions to environmental stress in elderly persons with anxiety disorders: evidence from a population study of diurnal cortisol changes. J Affect Disord 2008; 106: 307-313.
22. Muhsen K, Lipsitz J, Garty-Sandalon N, Gross R, Green MS. Correlates of generalized anxiety disorder: independent of comorbidity with depression: findings from the first Israeli National Health Interview Survey (2003-2004). Soc Psychiatry Psychiatr Epidemiol 2008; 43: 898-904.
23. Carroll D, Phillips AC, Gale CR, Batty GD. Generalized anxiety disorder is associated with reduced lung function in the Vietnam Experience Study. Psychosom Med 2011; 73: 716-720.
24. Brenes GA Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med 2003; 65: 963-970.
25. Abelson JL, Khan S, Giardino N. HPA axis, respiration and the airways in stress-a review in search of intersections. Biol Psychol 2010; 84: 57-65.
26. Taggart P, Critchley H, Lambiase PD. Heart-brain interactions in cardiac arrhythmia. Heart 2011; 97: 698-708.
27. Pereira VH, Cerqueira JJ, Palha JA, Sousa N. Stressed brain, diseased heart: a review on the pathophysiologic mechanisms of neurocardiology. Int J Cardiol 2013; 166: 30-37.
28. Fisher AJ, Newman MG. Heart rate and autonomic response to stress after experimental induction of worry versus relaxation in healthy, high-worry, and generalized anxiety disorder individuals. Biol Psychol 2013; 93: 65-74.
29. Chrousos GP Stress and disorders of the stress system. Nat Rev Endocrinol 2009; 5: 374-381.
30. Troisi A. Cholesterol in coronary heart disease and psychiatric disorders: same or opposite effects on morbidity risk? Neurosci Biobehav Rev 2009; 33: 125-132.
31. Suarez EC Relations of trait depression and anxiety to low lipid and lipoprotein concentrations in healthy young adult women. Psychosom Med 1999; 61: 273-279.
32. Conklin S, Stanford M. Premeditated aggression is associated with serum cholesterol in abstinent drug and alcohol dependent men. Psychiatry Res 2008; 157: 283-287.
33. Sooksawate T, Simmonds M. Influence of membrane cholesterol on modulation of the GABAA receptor by neuroactive steroids and other potentiators. Br J Pharmacol 2001; 134: 1303-1311.
34. Vink D, Aartsen MJ, Comijs HC, Heymans MW, Penninx BW, Stek ML et al. Onset of anxiety and depression in the aging population: comparison of risk factors in a 9-year prospective study. Am J Geriatr Psychiatry 2009; 17: 642-652.
35. de Beurs E, Beekman AT, Deeg DJ, Van Dyck R, van Tilburg W. Predictors of change in anxiety symptoms of older persons: results from the Longitudinal Aging Study Amsterdam. Psychol Med 2000; 30: 515-527.
36. Beaudreau SA, MacKay-Brandt A, Reynolds J. Application of a cognitive neuroscience perspective of cognitive control to late-life anxiety. J Anxiety Disord 2013; 27: 559-566. 7
37. Zhang X, Norton J, Carrière I, Ritchie K, Chaudieu I, Ancelin ML. Generalized anxiety in community-dwelling elderly: prevalence and clinical characteristics. J Affect Disord 2014; 172C: 24-29.
38. Goncalves DC, Pachana NA, Byrne GJ. Prevalence and correlates of generalized anxiety disorder among older adults in the Australian National Survey of Mental Health and Well-Being. J Affect Disord 2011; 132: 223-230.
39. Beekman AT, de Beurs E, van Balkom AJ, Deeg DJ, van Dyck R, van Tilburg W. Anxiety and depression in later life: co-occurrence and communality of risk factors. Am J Psychiatry 2000; 157: 89-95.
40. Newman MG, Llera SJ, Erickson TM, Przeworski A, Castonguay LG. Worry and generalized anxiety disorder: a review and theoretical synthesis of evidence on nature, etiology, mechanisms, and treatment. Annu Rev Clin Psychol 2013; 9: 275-297.
41. Beesdo K, Pine DS, Lieb R, Wittchen HU. Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder. Arch Gen Psychiatry 2010; 67: 47-57.
42. Faravelli C, Lo Sauro C, Lelli L, Pietrini F, Lazzeretti L, Godini L et al. The role of life events and HPA axis in anxiety disorders: a review. Curr Pharm Des 2012; 18: 5663-5674.
43. Ritchie K, Jaussent I, Stewart R, Dupuy AM, Courtet P, Malafosse A et al. Adverse childhood environment and late-life cognitive functioning. Int J Geriatr Psychiatry 2011; 26: 503-510.
44. Beluche I, Carriere I, Ritchie K, Ancelin ML. A prospective study of diurnal cortisol and cognitive function in community-dwelling elderly people. Psychol Med 2010; 40: 1039-1049.
45. Blay SL, Marinho V. Anxiety disorders in old age. Curr Opin Psychiatry 2012; 25: 462-467.
46. Butters MA, Bhalla RK, Andreescu C, Wetherell JL, Mantella R, Begley AE et al. Changes in neuropsychological functioning following treatment for late-life generalised anxiety disorder. Br J Psychiatry 2011; 199: 211-218.
47. Lenze EJ, Mantella RC, Shi P, Goate AM, Nowotny P, Butters MA et al. Elevated cortisol in older adults with generalized anxiety disorder is reduced by treatment: a placebo-controlled evaluation of escitalopram. Am J Geriatr Psychiatry 2011; 19: 482-490.
48. Domschke K, Deckert J. Genetics of anxiety disorders - status quo and quo vadis. Curr Pharm Des 2012; 18: 5691-5698.